Tag: Davidson


Industry on DTC Advertising Study: An Informed Patient Enables Better Care

Dec. 3, 2012 – Several industry advertising experts have weighed in regarding what message drug companies should take from a recent study published in Cancer regarding the impact of direct-to-consumer (DTC) advertising for aromatase inhibitors (AIs). The study, released in November, found that DTC advertising (DTCA) for AIs “was associated with increases in appropriate prescriptions […]

Read more